Bioprocessing White Papers

  1. Transforming QC Lab Scheduling In Pharmaceutical Manufacturing 10/13/2026

    QC lab scheduling in GMP facilities often runs on static tools disconnected from production. Synchronizing the two in real time changes how batch release, deviations, and capacity are managed.

  2. Transitioning mRNA Production To cGMP Requires Early Process Engagement 10/9/2026

    Early choices in capping strategy, IVT conditions, raw materials, and downstream design shape yield, cost, and quality in mRNA manufacturing, and can determine whether a cGMP campaign succeeds.

  3. Optimizing GMP Manufacturing Of Lipid Nanoparticles For mRNA Encapsulation 10/9/2026

    Moving mRNA lipid nanoparticle encapsulation from pre-clinical work to cGMP production is often underestimated. Early process parameter definition, raw material control, and scalable mixing determine how low-risk that transition becomes.

  4. Discover Accelerated Approaches For Successful Commercial Filing 10/9/2026

    Early risk assessment, leaner scale-down model qualification, and tighter process characterization scope offer the clearest time savings in microbial filings, each with scientific trade-offs worth weighing.

  5. Getting Started On A Successful Path To Microbial QC Automation 10/6/2026

    Moving microbial QC toward automation involves team-building, facility readiness, staff concerns, validation, regulatory alignment, and cost justification that extends well beyond simple labor savings.

  6. Sample-Attribute-Based Selection Strategies For AAV %Full Determination 10/2/2026

    AAV %Full analysis must distinguish full, empty, and partial capsids, with complementary methods selected according to sample characteristics, analytical needs, development stage, and context.

  7. Data-Centric Organoid Services For Predictive Drug Response And Next-Generation Oncology Research 10/1/2026

    Patient-derived organoids are gaining traction as translational tools in oncology, but their value depends on the quality and context of the data they generate, not the models alone.

  8. Product Carbon Footprint: Enabling Product-Level Decarbonization In Biopharma 10/1/2026

    Facility-level and spend-based carbon accounting leave critical gaps in biopharma Scope 3 management. This whitepaper examines how batch-level product carbon footprinting changes what's measurable and what's actionable.

  9. High-Performing Ionizable Lipids For Controlled Nucleic Acid Delivery 9/29/2026

    Ionizable lipids are central to effective mRNA delivery, influencing potency, biodistribution, and toxicity. See why advancing delivery beyond the liver will require stronger structure-function insights.

  10. Reliability By Design For Single-Use Bioprocessing 9/27/2026

    Success in single-use bioprocessing depends on design, supply, validation, and compliance. Learn how these factors support reliable, scalable, and resilient operations.